Top Markets
Coin of the day
QuantRx Biomedical Corporation QuantRx Biomedical Corporation

QuantRx Biomedical Corporation

QTXB
Pozycja w akcjach #40578
QuantRx Biomedical Corporation is engaged in the creation and marketing of its... QuantRx Biomedical Corporation is engaged in the creation and marketing of its patented miniature pads (PADs) and related over-the-counter (OTC) products within the United States. Additionally, the company is developing genomic diagnostic tools for the laboratory market, leveraging its proprietary lateral flow technologies, including the RapidSense single-step lateral flow test. The company's PAD products are designed to address a range of medical conditions such as hemorrhoids, mild vaginal infections, urinary incontinence, menstrual hygiene, and other general medical needs. Key offerings include InSync, an interlabial pad for feminine hygiene. Another significant product is the Unique miniform, which comes in two forms: a medicated pad providing temporary relief from the itching and discomfort associated with hemorrhoids and minor vaginal infections, and an unmedicated pad for daily management of light urinary, vaginal, or anal leakage. Other treated miniform products are also part of their portfolio. Established in 1986, QuantRx Biomedical Corporation is headquartered in Tualatin, Oregon.
Cena akcji
$0.0005
Ostatnia synchronizacja: 2025-04-08
Kapitalizacja rynkowa
$118.05K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel QuantRx Biomedical Corporation (QTXB)

Kategoria

EPS dla QuantRx Biomedical Corporation (QTXB)
EPS na dzień 2026 TTM: 0
Według najnowszych raportów finansowych i ceny akcji firmy QuantRx Biomedical Corporation, obecny EPS (TTM) wynosi 0. Na koniec roku 2026 firma miała EPS w wysokości 0, równa się do EPS z roku 2026, który wynosił 0.
Historia EPS dla QuantRx Biomedical Corporation od 2026 do 2026
EPS na koniec każdego roku
Rok EPS Zmień
Za mało danych dla podanych dat.
EPS dla podobnych firm lub konkurentów